We are live on ! Find out more
SP

Syncona Portfolio Portfolio holdings

AUM $25.7M
1-Year Est. Return 13.32%
This Fund
S&P 500
This Quarter Est. Return
+2.9%
1 Year Est. Return
+13.32%
3 Year Est. Return
+8.47%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$150M
AUM Growth
-$7.7M
Cap. Flow
-$10.4M
Cap. Flow %
-6.94%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
FRLN
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
+$9.33M
2
ADAP
Adaptimmune Therapeutics
ADAP
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AUTL
1
Autolus Therapeutics
AUTL
$386M
$136M 90.76%
21,346,829
– –
ACHL
2
DELISTED
Achilles Therapeutics
ACHL
$13.9M 9.24%
11,086,909
– –
ADAP
3
DELISTED
Adaptimmune Therapeutics
ADAP
– –
-1,377,294
Closed -$1.09M
FRLN
4
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
– –
-1,466,507
Closed -$9.33M

Similar funds

BAM
BTS Asset Management Lincoln, Massachusetts $25.9M AUM 2.16% 1-Year Est. Return
FCC
Florin Court Capital London, United Kingdom $26.5M AUM 34.2% 1-Year Est. Return
BWG
Berry Wealth Group Granbury, Texas $26.8M AUM 31.56% 1-Year Est. Return
LTM
Lotus Technology Management Orlando, Florida $27M AUM
TCM
Teza Capital Management Chicago, Illinois $27.3M AUM 29.09% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.5M AUM
BCM
Bancreek Capital Management Santa Monica, California $23.1M AUM 4.01% 1-Year Est. Return
BCM
BCK Capital Management Stamford, Connecticut $23M AUM 33.03% 1-Year Est. Return

Syncona Portfolio's Q1 2024 Portfolio in Review

As of Q1 2024, Syncona Portfolio held 4 positions worth $150M, down 4.9% from $158M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Syncona Portfolio withdrew a net $10.4M in Q1 2024, closing 2 positions. Its most notable exit was Freeline Therapeutics Holdings plc American Depositary Shares, an estimated $9.33M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Syncona Portfolio fully exited Freeline Therapeutics Holdings plc American Depositary Shares in Q1 2024, selling an estimated $9.33M.
  • Syncona Portfolio's ten largest holdings make up 100% of its $150M portfolio in Q1 2024.
  • Syncona Portfolio opened 0 new positions and closed 2 in Q1 2024.
  • Syncona Portfolio's portfolio value fell 4.9% quarter-over-quarter to $150M.

Based on Syncona Portfolio's 13F filing for Q1 2024, filed 7 May 2024.